Publications by authors named "Timothy Gayowski"

Claim this Profile
P
Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant.
Kyle P Ludwig, Heather F Thiesset, Timothy J Gayowski, Jason J Schwartz

Ann Pharmacother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-time, telemetric method for continuous measurement of portal pressures.
Jason Schwartz, Andreas Rohrwasser, Elaine Hillas, Jenny Hatch, John Sorensen, Timothy Gayowski

J Surg Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation for cholangiocarcinoma.
Jason J Schwartz, William R Hutson, Timothy J Gayowski, John B Sorensen

Transplantation· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hepatoadrenal syndrome: a common yet unrecognized clinical condition.
Paul E Marik, Timothy Gayowski, Thomas E Starzl,

Crit Care Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Marilyn M Wagener, Timothy Gayowski

Transplantation· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Timothy Gayowski, Marilyn M Wagener

Transplantation· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
Amadeo Marcos, Bijan Eghtesad, John J Fung, Paulo Fontes, Kusum Patel, Timothy Gayowski

Transplantation· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.
Nina Singh, Marilyn M Wagener, Asia Obman, Thomas V Cacciarelli, Michael E de Vera, Timothy Gayowski

Liver Transpl· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates.
Nina Singh, Shahid Husain, Michael de Vera, Timothy Gayowski, Thomas V Cacciarelli

Medicine (Baltimore)· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Marilyn M Wagener, Michael de Vera, Timothy Gayowski

Transplantation· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
David L Paterson, John D Rihs, Cheryl Squier, Timothy Gayowski, Asia Sagnimeni

Transplantation· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
Raman Venkataramanan, Shimin Zang, Timothy Gayowski, Nina Singh

Antimicrob Agents Chemother· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
Nina Singh, Marilyn M Wagener, Timothy Gayowski

Transplantation· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation.
Debra Hauser, Timothy Gayowski, Nina Singh

Transpl Int· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
Robert R Muder, Sangeeta Agarwala, Aja Mirani, Timothy Gayowski, Raman Venkataramanan

J Clin Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.
Nina Singh, Shahid Husain, Donald R Carrigan, Konstance K Knox, Karen E Weck, Timothy Gayowski

Clin Transplant· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.
Nina Singh, Marilyn M Wagener, Ignazio R Marino, Timothy Gayowski

Transplantation· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis